Page last updated: 2024-11-08

prolyl-leucyl-glycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

prolyl-leucyl-glycine: RN given refers to (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID169533
CHEMBL ID3251727
CHEBI ID162431
SCHEMBL ID1369569
MeSH IDM0155542

Synonyms (12)

Synonym
pro-leu-gly
33676-42-5
CHEBI:162431
2-[[(2s)-4-methyl-2-[[(2s)-pyrrolidine-2-carbonyl]amino]pentanoyl]amino]acetic acid
glycine, n-(n-l-prolyl-l-leucyl)-
prolyl-leucyl-glycine
CHEMBL3251727
SCHEMBL1369569
2-((s)-4-methyl-2-((s)-pyrrolidine-2-carboxamido)pentanamido)acetic acid
l-prolyl-l-leucyl-glycine
n-(1-hydroxy-2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}-4-methylpentylidene)glycine
DTXSID50955293

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oligopeptideA peptide containing a relatively small number of amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1136080Suppression of oxotremorine-induced tremor in ICR mouse at 20 mg/kg, ip pretreated for 1 hr followed by oxotremorine-challenge1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Study of the structural requirements for dopa potentiation and oxotremorine antagonism by L-prolyl-L-leucylglycinamide.
AID1136074Potentiation of dl-DOPA-induced behavioral effects in ICR mouse assessed as slight piloerection, slight salivation and slight increased motor activity at 10 mg/kg, ip administered 1 hr prior to dl-DOPA-challenge measured for 1 hr1978Journal of medicinal chemistry, Feb, Volume: 21, Issue:2
Study of the structural requirements for dopa potentiation and oxotremorine antagonism by L-prolyl-L-leucylglycinamide.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.09 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]